| Literature DB >> 35261284 |
Yuichi Saito1, Kazuya Tateishi1, Masato Kanda1, Yuki Shiko2, Yohei Kawasaki2, Yoshio Kobayashi1, Takahiro Inoue3.
Abstract
Background Lower primary percutaneous coronary intervention (PCI) volume is known to be associated with worse outcomes in patients with acute myocardial infarction (MI) at hospital level. The present study aimed to evaluate the relations of primary, elective, and total PCI volume and primary/total PCI volume ratio per hospital to in-hospital mortality in patients with acute MI undergoing primary PCI. Methods and Results Using a large nationwide administrative database, we included a total of 83 076 patients from 154 hospitals in Japan undergoing PCI for either acute MI or elective cases. Relations of annual procedural volumes for primary, elective, and total PCI to in-hospital mortality after acute MI at hospital level were evaluated. The ratio of primary to total PCI volume per hospital was also assessed. The primary end point was the ratio of observed to predicted mortality. Of 83 076 patients, 26 913 (32.4%) underwent primary PCI for acute MI, among whom 1561 (5.8%) died during hospitalization. Overall, observed in-hospital mortality after acute MI and observed/predicted mortality ratio were higher in hospitals with lower primary, elective, and total PCI volumes. Observed/predicted in-hospital mortality ratio was higher in hospitals with low primary/total PCI volume ratio, even in those with high total PCI volume. Conclusions Primary, elective, and total PCI volume at hospitals were inversely associated with in-hospital mortality in patients with acute MI undergoing primary PCI. Lower ratio of primary to total PCI volume were related to higher in-hospital mortality, suggesting primary/total PCI volume ratio as an institutional indicator of quality of care for acute MI.Entities:
Keywords: mortality; myocardial infarction; percutaneous coronary intervention; volume‐outcome relationship
Mesh:
Year: 2022 PMID: 35261284 PMCID: PMC9075272 DOI: 10.1161/JAHA.121.023805
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Study flow.
MI indicates myocardial infarction; and PCI, percutaneous coronary intervention.
Baseline Characteristics
| Variable | All (n=26 913) | In‐hospital death (+) (n=1561) | In‐hospital death (−) (n=25 352) |
|
|---|---|---|---|---|
| Age, y | 69.2±12.7 | 75.7±12.0 | 68.8±12.7 | <0.001 |
| Male | 20 422 (75.9%) | 1066 (68.3%) | 19 356 (76.4%) | <0.001 |
| Body mass index, kg/m2 | 24.0±3.8 | 23.2±4.0 | 24.0±3.8 | <0.001 |
| Hypertension | 18 365 (68.2%) | 449 (28.8%) | 17 916 (70.7%) | <0.001 |
| Diabetes | 8469 (31.5%) | 363 (23.3%) | 8106 (32.0%) | <0.001 |
| Dyslipidemia | 19 255 (71.6%) | 318 (20.4%) | 18 937 (74.7%) | <0.001 |
| Anterior MI | 11 414 (42.4%) | 774 (50.0%) | 10 640 (42.0%) | <0.001 |
| Killip class | <0.001 | |||
| Killip 1 | 12 535 (46.6%) | 142 (9.1%) | 12 393 (48.9%) | |
| Killip 2 | 6578 (24.4%) | 194 (12.4%) | 6384 (25.2%) | |
| Killip 3 | 1881 (7.0%) | 171 (11.0%) | 1710 (6.8%) | |
| Killip 4 | 3249 (12.1%) | 789 (50.5%) | 2460 (9.7%) | |
| Undetermined | 2670 (9.9%) | 265 (17.0%) | 2405 (9.5%) | |
| Cardiac arrest | 967 (3.6%) | 353 (22.6%) | 614 (2.4%) | <0.001 |
| IABP | 3194 (11.9%) | 701 (44.9%) | 2493 (9.8%) | <0.001 |
| ECMO | 423 (1.6%) | 278 (17.8%) | 145 (0.6%) | <0.001 |
| Medication | ||||
| Aspirin | 26 367 (98.0%) | 1344 (86.1%) | 25 023 (98.7%) | <0.001 |
| P2Y12 inhibitor | 26 362 (98.0%) | 1493 (95.6%) | 24 869 (98.1%) | <0.001 |
| Oral anticoagulant | 3334 (12.4%) | 159 (4.8%) | 3175 (12.5%) | <0.001 |
| Statin | 23 443 (87.1%) | 855 (54.8%) | 22 588 (89.1%) | <0.001 |
| ACEI or ARB | 16 440 (61.1%) | 371 (23.8%) | 16 069 (63.4%) | <0.001 |
| β‐blocker | 18 270 (67.9%) | 466 (29.9%) | 17 804 (70.2%) | <0.001 |
| Proton pump inhibitor | 23 380 (86.9%) | 1032 (66.1%) | 22 348 (88.2%) | <0.001 |
| Mechanical complications | 212 (0.8%) | 108 (6.9%) | 104 (0.4%) | <0.001 |
Data are mean±SD or n (%). Mechanical complication includes papillary muscle rupture, ventricular septal perforation, and free wall rupture. ACEI indicates angiotensin‐converting enzyme inhibitor; ARB, angiotensin II receptor blocker; ECMO, extracorporeal membrane oxygenation; IABP, intra‐aortic balloon pumping; and MI, myocardial infarction.
Figure 2Volumes of primary, elective, and total PCI, and ratio of primary to total PCI volume at hospitals.
MI indicates myocardial infarction; and PCI, percutaneous coronary intervention.
Figure 3Relations of primary, elective, and total PCI volumes to observed and predicted in‐hospital mortality and observed/predicted mortality ratio after acute MI.
MI indicates myocardial infarction; and PCI, percutaneous coronary intervention.
Figure 4Relations of primary/total PCI volume ratio to observed and predicted in‐hospital mortality after MI.
MI indicates myocardial infarction; and PCI, percutaneous coronary intervention.